Wednesday, November 18, 2009
Print Entire 2009 Program:
|
|
SESSION 1 SCHEDULE | |
Wednesday
SESSION 1:
HEMODIALYSIS ACCESS - PART 1
Moderators:TBD
|
|
x | |
7:50 AM - 7:59 AM | Introduction |
PART 1A: ACCESS PLANNING, DYSFUNCTIONAL FISTULAS AND CENTRAL VENOUS CATHETERS | |
Moderator(s): TBD | |
8:00 AM - 8:10 AM | Results Of The Dialysis Access Consortium: Where Do We Go From Here? |
8:11 AM - 8:21 AM | Does Physical Examination Have A Role In The Planning And Evaluation Of Hemodialysis Access? |
8:22 AM - 8:32 AM | Update On Ultrasound Imaging For Hemodialysis Access |
8:33 AM - 8:43 AM | Fundamentals Of Angiographic Evaluation Of AV Access |
8:44 AM - 8:54 AM | Facilitating Endovascular Access Procedures Using Flouro Trace |
8:55 AM - 9:05 AM | Management Of The Immature Fistula |
9:06 AM - 9:16 AM | Salvaging The Unsalvageable Fistula |
9:17 AM - 9:27 AM | Dialysis Catheters Are Bad News |
9:28 AM - 9:38 AM | Catheters Don’t Kill Patients |
9:39 AM - 9:59 AM | Panel Discussion |
10:00 AM - 10:20 AM | Break / Visit Exhibits |
PART 1B: MANAGEMENT OF CENTRAL VENOUS PROBLEMS | |
Moderator(s): TBD / TBD | |
10:21 AM - 10:31 AM | Pathophysiology Of Fibrin Sheath Development |
10:32 AM - 10:42 AM | Removal Of Embedded Catheters |
10:43 AM - 10:53 AM | Catheter Exchange Procedures |
10:54 AM - 11:04 AM | Catheter-Related Central Venous Stenosis |
11:05 AM - 11:15 AM | Pacemaker/Defibrillator Related Central Venous Stenosis |
11:16 AM - 11:26 AM | Power Wire For Central Venous Stenoses |
11:27 AM - 11:37 AM | Use Of The Peripheral Cutting Balloon For Treatment Of Cephalic Arch Stenosis Associated With Brachiocephalic Fistulas |
11:38 AM - 11:48 AM | Fatal Complications Of SVC Angioplasty |
11:49 AM - 12:10 PM | Panel Discussion |
12:10 PM - 1:05 PM | Lunch Break / Visit Exhibits |
END OF SESSION 1 | |
SESSION 2 SCHEDULE | |
Wednesday
SESSION 2:
HEMODIALYSIS ACCESS - PART 2
Moderators:TBD
|
|
x | |
PART 2A: HEMODIALYSIS ACCESS COMPLICATIONS / THROMBECTOMY PROCEDURES | |
Moderator(s): TBD / TBD | |
1:05 PM - 1:15 PM | Surgical vs. Percutaneous Thrombectomy: Which Is Best? |
1:16 PM - 1:26 PM | Techniques For Percutaneous Thrombectomy |
1:27 PM - 1:37 PM | Management Of Arterial Embolization During Percutaneous Thrombectomy Of Hemodialysis Grafts And Fistulas |
1:38 PM - 1:43 PM | Debate: Should Interventionalists Do Surgery: Pro |
1:44 PM - 1:49 PM | Debate: Should Interventionalists Do Surgery: Con |
1:50 PM - 2:00 PM | Vascular Access Hemorrhagic Deaths Among Hemodialysis Patients |
2:01 PM - 2:11 PM | Are Antiplatelet Drugs Or Anticoagulation Ever Indicated To Maintain Access Patency? |
2:12 PM - 2:32 PM | Panel Discussion |
2:33 PM - 2:55 PM | Break / Visit Exhibits |
PART 2B: UPDATE ON NEW TECHNOLOGIES (5 MINUTE TALKS) | |
Moderator(s): TBD / TBD | |
2:56 PM - 3:01 PM | Topical rThrombin For Wound Hemostasis |
3:02 PM - 3:07 PM | Role Of Heparin Bonded ePTFE Grafts In Dialysis Access |
3:08 PM - 3:13 PM | Preliminary Experience With The Duraspan Hemodialysis Catheter |
3:14 PM - 3:19 PM | Recombinant Human Elastase For Improved Vascular Access |
3:20 PM - 3:30 PM | Panel Discussion |
PART 2C: IMPORTANT TOPICS IN VASCULAR ACCESS | |
Moderator(s): TBD / TBD | |
3:31 PM - 3:41 PM | Optimizing Hemodialysis Cannulation Methods: Role Of Buttonhole Cannulation |
3:42 PM - 3:52 PM | Clinical Practice Guidelines For Hemodialysis Access |
3:53 PM - 4:03 PM | Reimbursement For Vascular Access: What Does The Future Hold? |
4:04 PM - 4:14 PM | Vascular Access Surveillance And The CMS MAT-V551 Requirement |
4:15 PM - 4:25 PM | Radial-to-Cephalic Arteriovenous Fistulas As A Method Of Choice In Children And Adolescents |
4:26 PM - 4:36 PM | Perfect Dialysis Access Graft: Are We There Yet? |
4:37 PM - 4:47 PM | Ischemic Monomelic Neuropathy |
4:48 PM - 5:10 PM | Panel Discussion |
5:10 PM - 5:10 PM | Adjourn |
END OF SESSION 2 | |
SESSION 3 SCHEDULE | |
Wednesday
SESSION 3:
NEW HORIZONS IN CARDIOVASCULAR SURGERY: MANAGEMENT OF AORTIC DISEASE - PART 1
Moderators: / TBD
|
|
x | |
12:30 PM - 12:40 PM | Opening Remarks |
12:40 PM - 1:40 PM | Case Studies: Clinical Presentation |
Presenters(s):Hazim J. Safi, MD | |
1:40 PM - 1:55 PM | What Imaging Won’t Tell Us About Aortic Disease |
1:55 PM - 2:10 PM | Genetic Disorders: Implications And Testing Efforts |
2:10 PM - 2:25 PM | Proximal Dissections: Acute Treatment Objectives And Long-Term Results |
2:25 PM - 2:40 PM | Surgical Education In The Era Of Rapidly Developing New Technologies |
2:40 PM - 2:55 PM | Pure Endovascular TAA Repair Techniques And Future |
2:55 PM - 3:10 PM | Contrast Between Open And Endovascular Repair Of Thoracoabdominal Aneurysms |
3:10 PM - 3:25 PM | Elephant Trunk Technique For The Treatment Of Extensive Thoracic Aortic Aneurysms |
3:25 PM - 3:40 PM | Spinal Cord Protection For TAA Repair |
3:40 PM - 3:55 PM | Endovascular Approaches To Aortic Arch Disease |
3:55 PM - 4:15 PM | Break |
END OF SESSION 3 | |
SESSION 4 SCHEDULE | |
Wednesday
SESSION 4:
NEW HORIZONS IN CARDIOVASCULAR SURGERY: MANAGEMENT OF AORTIC DISEASE - PART 2
Moderators: / TBD
|
|
x | |
4:15 PM - 6:00 PM | Follow-up Case Studies: Management And Outcome |
Presenters(s):Hazim J. Safi, MD | |
6:00 PM - 6:00 PM | |
END OF SESSION 4 | |
SESSION 5 SCHEDULE | |
Wednesday
SESSION 5:
ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 1
Moderators: / TBD
|
|
x | |
8:00 AM - 8:09 AM | Welcoming Remarks |
8:10 AM - 8:19 AM | How To Identify The Best Patients For Endovenous Thermal Ablation |
8:20 AM - 8:29 AM | Which Patients Are Not Suitable For Endovenous Thermal Ablation? |
8:30 AM - 8:39 AM | Generating The Venous Map With Duplex Ultrasound |
8:40 AM - 8:49 AM | Great Saphenous vs. Small Saphenous Vein Ablation: Similarities And Differences Of Procedure |
8:50 AM - 8:59 AM | Endovenous Thermal Ablation: How I Choose Between RF Or Laser |
9:00 AM - 9:09 AM | Catheter-Directed Foam Sclerotherapy Treatment Of Saphenous Vein Incompetence |
9:10 AM - 9:19 AM | Lessons Learned After 3,000 Endovenous Ablations |
9:20 AM - 9:35 AM | Panel Discussion |
9:36 AM - 9:45 AM | Fire, Foam, And Knife For Varicose Veins: What Have Prospective Randomized Clinical Trials Taught Us? |
9:46 AM - 9:55 AM | What Studies Are Needed To Help Vein Doctors Treat Patients Better? |
9:56 AM - 10:05 AM | Preservation Of The Saphenous Vein In Patients With Varicose Veins |
10:06 AM - 10:15 AM | The CHIVA Approach To Varicose Vein Treatment |
10:16 AM - 10:25 AM | Matrix Metalloproteinases And Varicose Veins |
10:26 AM - 10:35 AM | Current Information On The Development And Treatment Of Venous Ulcers |
10:36 AM - 10:45 AM | How To Treat Ascending GSV Superficial Thrombophlebitis |
10:46 AM - 10:54 AM | Ileofemoral Venous Reflux And Obstruction: Diagnosis And Treatment |
10:55 AM - 11:04 AM | Venous Stenting: When, Where, Whom, How? |
11:05 AM - 11:14 AM | Deep Vein Considerations During Superficial Venous Treatment |
11:15 AM - 11:24 AM | The Future Of Venous Imaging: Will It Be Duplex Ultrasound, MRV, Or CTV? |
11:25 AM - 11:34 AM | Pelvic Venous Syndromes |
11:35 AM - 11:44 AM | Are Surgeons Letting Vein Care Slip Away?: Are Phlebologists Taking Over? |
11:45 AM - 12:00 PM | Panel Discussion |
12:00 PM - 12:30 PM | Lunch Break |
END OF SESSION 5 | |
SESSION 6 SCHEDULE | |
Wednesday
SESSION 6:
ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 2
Moderators: / TBD
|
|
x | |
12:30 PM - 12:39 PM | DVT Update: Current Recommendations For Treatment And Prophylaxis |
12:40 PM - 12:49 PM | Current Data On Radiofrequency Ablation With The ClosureFAST Catheter |
12:50 PM - 12:59 PM | Venous Laser Updates: New Wavelength Or Fibers? |
1:00 PM - 1:09 PM | Management Of The Anticoagulated Patient Who Needs Endovenous Ablation And Phlebectomy |
1:10 PM - 1:19 PM | Phlebectomy, Trivex, Or Sclerotherapy For Bulging Varicose Vein Tributaries? |
1:20 PM - 1:29 PM | Foam vs. Liquid Sclerotherapy In The Management Of Varicose Veins |
1:30 PM - 1:39 PM | Considerations For Treatment Of Infrapopliteal Deep Venous Thrombosis |
1:40 PM - 1:49 PM | Thrombotic Complications Of Endovenous Therapy For Varicose Veins |
1:50 PM - 1:59 PM | Thrombophilia: When To Order? What To Order? How To Treat And For How Long? |
2:00 PM - 2:09 PM | Should Adjuvant Procedures Be Performed At The Same Time As Endothermal Ablation?: Evidence Based |
2:10 PM - 2:19 PM | When Should Perforators Be Considered For Treatment? |
2:20 PM - 2:29 PM | Recurrent Varicose Veins: Can They Be Prevented? Can They Be Treated Effectively? |
2:30 PM - 2:39 PM | Role Of Laser vs. Sclerotherapy For Spider Telangiectasias? |
2:40 PM - 2:49 PM | Management Of Venous Malformations: Cut, Cook, Squirt? |
2:50 PM - 3:00 PM | Complications Of Foam Sclerotherapy: What I Have Witnessed |
3:00 PM - 3:10 PM | Establishing VTE Protocols For Prevention And Intervention |
3:10 PM - 3:20 PM | Building Your DVT Practice |
3:20 PM - 3:50 PM | Ask The Panel |
Panelist(s): Jose I. Almeida, MD, FACS, RVT / Lowell S. Kabnick, MD, FACS, FACPh / Ronald G. Bush, MD / Edward G. Mackay, MD / Thomas F. O'Donnell, Jr., MD / Peter F. Lawrence, MD / Peter J. Pappas, MD / Peter H. Lin, MD | |
3:50 PM - 3:50 PM | Adjourn |
END OF SESSION 6 | |
SESSION 7 SCHEDULE | |
Wednesday
SESSION 7:
WOUNDS - PART 1
Moderators:TBD
|
|
x | |
8:00 AM - 8:10 AM | Opening Remarks |
PART 1A: NEW CONCEPTS IN WOUND CARE | |
Moderator(s): TBD | |
8:10 AM - 8:20 AM | Effect Of Different Frequencies Of Tensile Strain On Human Dermal Fibroblast Proliferation And Survival: Implication For The Practical Use |
8:20 AM - 8:30 AM | Discussion |
8:30 AM - 8:40 AM | The Use Of Skin Perfusion Pressure (SPP) With Pulse Volume Recording (PVR) To Accurately Assess Micro And Macro Circulation- Predicting Wound Healing |
8:40 AM - 8:50 AM | Discussion |
8:50 AM - 9:00 AM | Calciphylaxis And Martotell's Ulcer Need Fast Track Surgical Treatment |
9:00 AM - 9:10 AM | Discussion |
9:10 AM - 9:20 AM | Charged Polystyrene Microspheres: A New Technology For Treating Hard To Heal Chronic Wounds |
9:20 AM - 9:30 AM | Discussion |
9:30 AM - 9:40 AM | Autologous Platelet-Rich Fibrin Membrane In The Treatment Of Patients With Chronic Lower Extremity Ulcers |
9:40 AM - 9:50 AM | Discussion |
9:50 AM - 10:00 AM | Panel Discussion |
10:00 AM - 10:30 AM | Break / Visit Exhibits |
PART 1B: MEETINGS SUMMARY | |
Moderator(s): TBD | |
10:30 AM - 11:00 AM | Best From WUWHS Meeting 2008 |
11:00 AM - 11:15 AM | Discussion |
11:15 AM - 11:45 AM | Best From DFCON Meeting |
11:45 AM - 12:00 PM | Discussion |
12:00 PM - 1:00 PM | Lunch Break |
END OF SESSION 7 | |
SESSION 8 SCHEDULE | |
Wednesday
SESSION 8:
WOUNDS - PART 2
Moderators:TBD
|
|
x | |
PART 2A: WOUND HEALING SOCIETIES | |
Moderator(s): TBD | |
1:00 PM - 1:10 PM | Introducing The Swiss Association for Wound Care (SAfW) |
PART 2B: EVIDENCE BASED MEDICINE IN WOUND CARE | |
Moderator(s): TBD | |
1:10 PM - 1:20 PM | An Overview Of Level 1 Evidence From Cochrane Systematic Reviews On Systemic Wound Care |
1:20 PM - 1:30 PM | Discussion |
1:30 PM - 1:40 PM | Effectiveness Of Iodine In Wound Care: A Systematic Review |
1:40 PM - 1:50 PM | Discussion |
1:50 PM - 2:00 PM | Applying Evidence-Based Wound Healing To Difficult Chronic Wounds |
2:00 PM - 2:10 PM | Discussion |
2:10 PM - 2:20 PM | Evidence Informed Practice: A New Approach To Evidence Based Medicine |
2:20 PM - 2:30 PM | Discussion |
2:30 PM - 3:00 PM | Break / Visit Exhibits |
PART 2C: CHALLENGES OF INTERDISCIPLINARY WOUND TEAMS | |
Moderator(s): TBD | |
3:00 PM - 3:10 PM | How To Get The Interdisciplinary Team To Talk And To Work In The Clinic |
3:10 PM - 3:20 PM | The Challenges Of An Open Access Interdisciplinary Foot Clinic And How To Overcome Them |
3:20 PM - 3:30 PM | The Role Of The Dermatologist In The Interdisciplinary Wound Team |
3:30 PM - 3:40 PM | The Role Of The Orthopedic Surgeon In The Interdisciplinary Wound Team |
3:40 PM - 3:50 PM | The Role Of The Vascular Surgeon In The Interdisciplinary Wound Team |
3:50 PM - 4:00 PM | The Role Of The Diabetologist In The Interdisciplinary Wound Team |
4:00 PM - 4:20 PM | Panel Discussion |
PART 2D: VASCULAR INTERVENTIONS IN WOUND CARE | |
Moderator(s): TBD | |
4:20 PM - 4:30 PM | Debate: Balloon Angioplasty Is First Choice In All Wound Patients Suffering From Critical Limb Ischemia |
4:30 PM - 4:40 PM | Debate: Balloon Angioplasty Is Not First Choice In All Wound Patients Suffering From Critical Limb Ischemia |
4:40 PM - 4:50 PM | Discussion |
4:50 PM - 5:00 PM | Debate: Endovenous Ablation Is The Best Choice For Prevention Of Recurrent Venous Stasis Ulcers |
5:00 PM - 5:10 PM | Debate: Endovenous Ablation Is Not The Best Choice For Prevention Of Recurrent Venous Stasis Ulcers |
5:10 PM - 5:20 PM | Discussion |
5:20 PM - 5:30 PM | Closing Remarks |
END OF SESSION 8 | |
Thursday, November 19, 2009
Print Entire 2009 Program:
|
|
SESSION 9 SCHEDULE | |
Thursday
SESSION 9:
TOPICS OF INTEREST TO INTERVENTIONALISTS, CARDIAC SURGEONS AND VASCULAR SURGEONS: ENDOVASCULAR HEART VALVES, ASCENDING AORTA AND ARCH LESIONS, IN SITU FENESTRATION, IMPROVED OPEN SURGICAL APPROACHES
Moderators: / TBD
|
|
x | |
6:35 AM - 6:40 AM | Opening Remarks |
6:40 AM - 6:45 AM | Training Issues In Cardiac Surgery |
Presenters(s):Grayson H. Wheatley, MD | |
6:46 AM - 6:51 AM | Access Problems With Endovascular Aortic Valve Repair And How To Handle Them |
6:52 AM - 6:57 AM | Updated Experience With The Percutaneous Self-Expanding CORE Aortic Valve |
6:58 AM - 7:03 AM | Current State-of-the-Art With Endovascular Aortic Valve Repair |
Presenters(s):Martin B. Leon, MD | |
7:04 AM - 7:09 AM | Overview Of Percutaneous And Other Less Invasive Mitral Valve Treatments |
Presenters(s):Ted Feldman, MD | |
7:10 AM - 7:15 AM | The Future For Endovascular Repair Of Type A Aortic Dissections: Concept And Initial Clinical Experience |
7:16 AM - 7:22 AM | Panel Discussion |
7:22 AM - 7:27 AM | Where Are We With Branched Grafts For Treatment Of Aortic Arch Lesions? |
7:28 AM - 7:33 AM | Aortic External Graft Wrapping Makes Hybrid Procedures Successful And The Best Treatment For Aortic Arch Pathology: Technical Tips For Doing It Right |
7:34 AM - 7:39 AM | Open Repair Is Still The Best Option For Arch Aneurysms In Most Patients |
Presenters(s):Hazim J. Safi, MD | |
7:40 AM - 7:45 AM | Aortic Arch And TAA Repair Via A Left Thoracotomy: A New Technique |
7:46 AM - 7:51 AM | Is In Situ Fenestration The Way To Go For Revascularization Of Supra-Aortic Branches In Association With Endovascular Repair Of Arch Aneurysms? |
7:52 AM - 7:57 AM | Endovascular Total Arch Replacement Using In Situ Fenestration Methods: Techniques, Tricks And Early Clinical Experience |
Presenters(s):Bjõrn Sonesson, MD, PhD | |
7:58 AM - 8:04 AM | Panel Discussion |
END OF SESSION 9 | |
SESSION 10 SCHEDULE | |
Thursday
SESSION 10:
MORE ABOUT THORACIC ENDOGRAFTING AND TREATMENT OF DISSECTING ANEURYSMS (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
8:04 AM - 8:09 AM | What Is Optimal Medical Treatment For Type B Aortic Dissections: How Well Does It Work? |
Presenters(s):Christoph A. Nienaber, MD, PhD | |
8:10 AM - 8:15 AM | Debate 1: All Acute Type B Aortic Dissections Should Be Treated With An Endograft: We Don’t Need Level I Evidence |
8:16 AM - 8:21 AM | Debate 1: Nonsense, We Do Need Level I Evidence Comparing Medical Treatment With TEVAR For Uncomplicated Type B Aortic Dissection: Early Results Of Such A Trial (The ADSORB Trial) |
8:22 AM - 8:27 AM | Lessons Learned In Endograft Treatment Of More Than 550 Patients With Type B Aortic Dissections: How To Manage Retrograde Type A Dissections |
Presenters(s):Wei Guo Fu, MD | |
8:28 AM - 8:33 AM | Debate 2: For Type B Aortic Dissections Short TEVAR Coverage Of The Primary Tear Is Best |
8:34 AM - 8:39 AM | Debate 2: For Type B Aortic Dissections TEVAR Should Cover The Entire Thoracic Aorta |
8:40 AM - 8:45 AM | Oral Anticoagulation In Type B Aortic Dissections Has A Beneficial Effect On Secondary Dilatation And Malperfusion |
8:46 AM - 8:51 AM | Potential Devices For Complete Endovascular Repair Of Complex Type B Aortic Dissecting Aneurysms: The Hollow Hat Small Endograft For Leaks At Branch Reentry Sites |
Presenters(s):Zaiping Jing, MD | |
8:52 AM - 8:57 AM | Experience With Endo TAA Repair With Branched Endografts: When Can This Technology Not Be Used? |
8:58 AM - 9:03 AM | Single Center Experience With Treatment Of Malperfusion From Type B Aortic Dissections |
9:04 AM - 9:10 AM | Panel Discussion |
END OF SESSION 10 | |
SESSION 11 SCHEDULE | |
Thursday
SESSION 11:
NEW DEVELOPMENTS AND TECHNIQUES IN TEVAR AND DEALING WITH ITS COMPLICATIONS (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
9:10 AM - 9:15 AM | Debate 3: Left Subclavian Artery Coverage During TEVAR Is Relatively Safe: When Is It Not? |
9:16 AM - 9:21 AM | Debate 3: Left Subclavian Artery Flow Must Be Preserved During TEVAR: If Covered The Left Subclavian Must Be Revascularized |
9:22 AM - 9:27 AM | Management Of Recurrent Aneurysms After TEVAR From Endograft Failure Or Disease Progression |
Presenters(s):Geoffrey H. White, MD | |
9:28 AM - 9:33 AM | What Are Malignant Aortic Dissections And How Are They Best Treated Endovascularly: The MAD REDEEM Concept |
Presenters(s):Christoph A. Nienaber, MD, PhD | |
9:34 AM - 9:39 AM | Direct Placement Of Large Sheaths In The Aorta Or Common Iliacs For TEVAR: Techniques And Tricks For Doing It Safely |
9:40 AM - 9:45 AM | Computational Hemodynamics And Its Importance In Acute Thoracic Aortic Disease |
9:46 AM - 9:51 AM | New Endovascular Procedures For Better Treatment Of Chronic Type B Dissections With Aneurysm Formation |
9:52 AM - 9:57 AM | TEVAR After Previous AAA Repair Is Relatively Safe: When Is Spinal Drainage Necessary? |
9:58 AM - 10:03 AM | A Blood Test For Thoracic Aortic Aneurysms |
10:04 AM - 10:09 AM | Use Of Atrium ICAST Covered Stents To Treat Aortic Coarctation And Associated Aneurysms: Are They Safer Than Bare Stents? |
10:10 AM - 10:18 AM | Panel Discussion |
END OF SESSION 11 | |
SESSION 12 SCHEDULE | |
Thursday
SESSION 12:
HOT TOPICS IN LOWER EXTREMITY ENDOVASCULAR TREATMENT (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
6:40 AM - 6:45 AM | Opening Remarks |
6:45 AM - 6:50 AM | Overview Of Atherectomy Devices: What Is The Evidence They Add Anything But Cost? |
6:51 AM - 6:56 AM | Debate 4: Rotational Atherectomy Devices Really Work In Certain Specific Situations: What Are They? What Is The Proof? |
6:57 AM - 7:03 AM | Debate 4: Atherectomy Devices Are A Waste Of Time And Money |
7:04 AM - 7:09 AM | Value And Limitations Of The ANGIOSCULPT Scoring/Cutting PTA Balloon For Infrapopliteal Lesions: 2-Year Results Of The MASCOT Trial: Will This Decrease The Need For Stents? |
7:10 AM - 7:15 AM | Cool Excimer Laser Assisted PTA vs. Balloon PTA With New Improved Balloons For Tibial Occlusive Disease Causing Critical Limb Ischemia (CLI): Is The Laser Of Real Value And When? |
7:16 AM - 7:21 AM | Tips, Tricks And Bailout Strategies For Subintimal Angioplasty Of Long Infrainguinal Occlusions |
7:22 AM - 7:27 AM | Debate 5: Update And 12-Month Results With Drug Eluting Balloons Show Clear Benefit For Treating SFA And Popliteal Lesions |
7:28 AM - 7:33 AM | Debate 5: It Is Not So Clear That Drug Eluting Balloons Work |
7:34 AM - 7:39 AM | Prevention And Treatment Of In-Stent Restenosis |
7:40 AM - 7:45 AM | Will Long Nitinol Stents (Like the 20 cm EVERFLEX) Replace Bypass Surgery For Long Fempop Occlusions? |
7:46 AM - 7:58 AM | Panel Discussion |
END OF SESSION 12 | |
SESSION 13 SCHEDULE | |
Thursday
SESSION 13:
MORE LOWER EXTREMITY HOT TOPICS, ESPECIALLY REGARDING STENTS (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
7:59 AM - 8:04 AM | Role Of Current Stents In Lower Extremity Occlusive Disease In 2009: What Is The Most Recent Evidence Including That From The STRIDES And VIASTAR Studies? |
8:05 AM - 8:10 AM | 2-Year Results Of The ZILVER-PTX Drug-Eluting Stent For SFA Lesions |
8:11 AM - 8:16 AM | Status Of The TURBO BOOSTER Spectranetics Laser For Lower Extremity Occlusive Disease: Has It Changed Things? |
8:17 AM - 8:22 AM | New Concepts In Stent Design: The Micromesh-Covered SESAME Stent: Design And Clinical Experience |
8:23 AM - 8:28 AM | Technical Tips And Results Of Transpedal Approach For Revascularizing Tibial Artery Occlusions Which Cannot Be Crossed From Above |
8:29 AM - 8:34 AM | Indication And Techniques For Transpedal Approach In The Treatment Of Critical Limb Ischemia |
8:35 AM - 8:40 AM | New Technique For Distal PTA Of Tibial Arteries: The Pedal Arch Route For Access: Can It Work In Diabetics? |
8:41 AM - 8:46 AM | Need For Distal Embolic Filtration Devices With Lower Extremity Atherectomy And Laser Angioplasty |
8:47 AM - 8:52 AM | Incidence Of Embolization After Lower Extremity Percutaneous Revascularization |
8:53 AM - 8:58 AM | Choice Of Access For Below-Knee Interventions: Up And Over vs. Antegrade |
8:59 AM - 9:10 AM | Panel Discussion |
END OF SESSION 13 | |
SESSION 14 SCHEDULE | |
Thursday
SESSION 14:
MORE LOWER EXTREMITY HOT TOPICS (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
9:10 AM - 9:15 AM | Devices And Simplified Strategies For Crossing Total Occlusions |
9:16 AM - 9:21 AM | Value And Limitations Of Drug-Eluting Stents (DES) In The Treatment Of Critical Limb Ischemia (CLI) |
9:22 AM - 9:27 AM | DES vs. Bare Metal Stents (BMS) To Treat Below-Knee Lesions: 1-Year Angiographic Results Of The DESTINY Trial |
9:28 AM - 9:33 AM | Below-Knee DES For CLI: Results With 2-Year Follow-Up |
9:34 AM - 9:39 AM | Intraoperative Stem Cell Treatment Delivered With A Novel Device To Improve Limb Salvage Rates |
Presenters(s):Ralf R. Kolvenbach, MD | |
9:40 AM - 9:45 AM | Debate 6: DES In The SFA Will Have A Positive Impact |
9:46 AM - 9:51 AM | Debate 6: DES In The SFA Are Not Needed |
9:52 AM - 9:57 AM | 5-Year Results With Zilver Stents Across The Knee Are Good |
9:58 AM - 10:03 AM | With Foot Gangrene And Ulceration Wound Healing Occurs Faster And Better With A Bypass Than With Endovascular Treatments |
10:04 AM - 10:18 AM | Panel Discussion CONCLUSION OF PROGRAMS A AND B. AIMsymposium continues in the Trianon Ballroom, 3rd Floor as Plenary Sessions. VEITHsymposium continues in the Grand Ballroom, 3rd Floor as Plenary Sessions. |
END OF SESSION 14 | |
SESSION 15 SCHEDULE | |
Thursday
SESSION 15:
NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENTS AND MANAGEMENT OF CLI (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
10:20 AM - 10:25 AM | Advanced Interventional Techniques In Fempop And Crural Arteries For CLI: The Role Of Plain Old Balloon PTA (POBA) |
10:26 AM - 10:31 AM | Debate 7: New Developments In Subintimal Angioplasty: It Is A Desirable Method |
10:32 AM - 10:37 AM | Debate 7: Subintimal Angioplasty For CLI Is A Technical Error Not A First Choice Procedure |
10:38 AM - 10:43 AM | Advantages, Disadvantages And Technical Tips For Subintimal Angioplasty |
10:44 AM - 10:49 AM | New Options For Restenosis In The SFA |
10:50 AM - 10:55 AM | ICAST Balloon-Expandable Stents And Covered Stents In The Lower Extremity: Results Of The ICARUS Trial |
10:56 AM - 11:01 AM | Endovascular Methods To Treat Severely Calcified SFAs Successfully |
11:02 AM - 11:07 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
11:07 AM - 11:12 AM | Debate 8: TASC II Is A Good Decision Making Tool |
11:13 AM - 11:18 AM | Debate 8: TASC II Is Too Complicated And Not Worthwhile As A Treatment Guide |
11:19 AM - 11:24 AM | Methods For Stenting Infrainguinal Lesions At Bifurcations Safely And Effectively: Something We All Need To Know |
11:25 AM - 11:30 AM | Stenting Of Lesions At Tibial Bifurcations: Indications And Techniques |
11:31 AM - 11:36 AM | Debate 9: Endovascular Techniques Can Effectively Treat Virtually All Patients With CLI: Open Surgery Is Almost Never Needed |
11:37 AM - 11:42 AM | Debate 9: What Proportion Of CLI Patients Will Need An Open Surgical Procedure At Some Point In Their Course: An Interventionalist’s Perspective |
11:43 AM - 11:48 AM | Debate 9: What Proportion Of CLI Patients Will Need An Open Surgical Procedure At Some Point In Their Course: A Vascular Surgeon’s Perspective |
11:49 AM - 11:54 AM | Debate 9: Open Surgical Bypass Is The Procedure Of Choice For CLI Revascularization |
11:55 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Served in the Exhibit Hall and in Other Designated Areas |
END OF SESSION 15 | |
SESSION 16 SCHEDULE | |
Thursday
SESSION 16:
NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
1:00 PM - 1:05 PM | A New Technique For In Situ Fenestration To Revascularize Aortic Branches Using Electro-Magnetic Navigation |
1:06 PM - 1:11 PM | When Can Type I Endoleaks After EVAR Be Safely Observed? |
1:12 PM - 1:17 PM | How Well Is The Petticoat Concept (Open Stent Distal to a Stent-Graft) Working For Treatment Of Type B Dissections? |
Presenters(s):Christoph A. Nienaber, MD, PhD | |
1:18 PM - 1:23 AM | Update On The STABLE Trial With A Thoracic Endograft, Comprised Of A Covered Stent Above And An Open Stent Below, For Type B Aortic Dissections |
1:24 PM - 1:29 PM | Experience With Hybrid Grafting Of The Visceral And Renal Arteries From The Ascending Aorta: Is It A Better Way? |
1:30 PM - 1:35 PM | 8-Year Experience With The VORTEC Procedure: Viabahn Technique For Revascularization Of Aortic Branch Vessels Without Clamping Or Circumferential Dissection: Is It A Better Way? |
1:36 PM - 1:41 PM | An Improved Preloaded Fenestrated Endograft For Pararenal AAAs: Advantages, Technical Description And Initial Clinical Experience |
1:42 PM - 1:47 PM | Panel Discussion |
Moderator(s): TBD / TBD | |
1:47 PM - 1:52 PM | Tissue Glue And Coil Embolization For Difficult Type I Endoleaks: Technique And Midterm Results |
1:53 PM - 1:58 PM | Optimal Techniques For Surveillance After EVAR In 2009 And Beyond |
1:59 PM - 2:04 PM | AAA Sac Pressure Measurements Are Helpful Since Many Type II Endoleaks Should Be Treated Because They Can Cause AAA Ruptures |
2:05 PM - 2:10 PM | Technique For Continuous Supraceliac Balloon Aortic Control With Ruptured AAAs And Hemodynamic Collapse (Video Presentation) |
2:11 PM - 2:16 PM | A New System For Electronic Image Marking To Simplify Interventional Procedures |
2:17 PM - 2:22 PM | Is EVAR The Treatment Of Choice For Inflammatory AAAs? |
2:23 PM - 2:28 PM | Panel Discussion |
END OF SESSION 16 | |
SESSION 17 SCHEDULE | |
Thursday
SESSION 17:
CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2009 (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
2:28 PM - 2:33 PM | Debate 10: CAS Is Dead Based On Population Based Studies And Level I Evidence |
2:34 PM - 2:39 PM | Debate 10: CAS Is Not Dead: It Will Have A Role In Symptomatic Patients When Used With New And Better Technology (Better Stents/Flow Reversal) And Better Patient Selection |
2:40 PM - 2:45 PM | Anatomic And Lesion Characteristics Are Accurate Predictors Of Stroke From CAS: What Technique Is Best For Determining This? |
2:46 PM - 2:51 PM | New Key Information From The SPACE Trial: Cerebral Protection vs. No Cerebral Protection: Timing Of Strokes With CAS; Incidence Of Restenosis After CAS And CEA; Open vs. Closed Stents – Which Is Best? |
2:52 PM - 2:58 PM | Results Of The ICSS Trial: Randomized Comparison Of CAS vs. CEA In Symptomatic Patients |
2:59 PM - 3:04 PM | 1-Year Results Of The CREST Trial: Randomized Comparison Of CAS vs. CEA In Symptomatic And Asymptomatic Patients |
3:05 PM - 3:10 PM | Where Do We Go From Here With Randomized Trials Of CAS vs. CEA: Do We Need More Trials In Asymptomatic Patients With A Best Medical Treatment Arm; More Trials With Better Patient Selection; Or More Trials With Better Technology For CAS (Flow Reversal and Better Stent Systems)? |
3:11 PM - 3:16 PM | CAS With Proximal Protection (Flow Cessation/Reversal) And Hybrid (Cristallo) Stents: Will This Be A Better And Universally Safe Approach? |
3:17 PM - 3:22 PM | Debate 11: Indirect Markers Of Cerebral Embolization (TCD and Diffusion-Weighted MRI) Are Of Great Value In Differentiating Strategies For Embolic Protection In CAS |
3:23 PM - 3:28 PM | Debate 11: Indirect Markers Of Cerebral Embolization (TCD and DW-MRI) Are Of Little Value In Differentiating Strategies For Embolic Protection In CAS Because Most Strokes With CAS Occur Before Or After Embolic Protection Devices Are Functioning |
3:29 PM - 3:34 PM | Imaging Suite Of The Future Will Combine Many Modalities: What Can Be Combined With Fluoroscopy To Facilitate Endovascular Procedures? |
3:35 PM - 3:40 PM | Panel Discussion |
Moderator(s): TBD / TBD / TBD | |
3:40 PM - 3:45 PM | Debate 12: Medical Treatment Is Best For Most Asymptomatic Patients With Carotid Stenosis |
3:46 PM - 3:51 PM | Debate 12: CEA Or CAS, Not Medical Treatment, Is Best For Most Asymptomatic Patients With >60% Carotid Stenosis |
3:52 PM - 3:57 PM | Interventional Treatment (CAS or CEA) Should Await New Diagnostic Methods: What Is On The Horizon? |
3:58 PM - 4:03 PM | Best Medical Treatment Is Currently The Optimal Management For >60% Carotid Stenosis In Asymptomatic Patients: What Is Needed To Maximize The Benefit Of CAS In Such Patients? |
4:04 PM - 4:09 PM | Value Of Intense Lipid Lowering Treatment In Patients With Asymptomatic Carotid Stenosis |
4:10 PM - 4:15 PM | How To Identify Vulnerable Carotid Plaques In Asymptomatic Patients Noninvasively With Molecular Imaging |
4:16 PM - 4:21 PM | How To Predict Which Asymptomatic Patients Are At High Risk For Stroke So They Can Be Treated Invasively Without Treating All Asymptomatic Patients: Present Status And Future Possibilities |
4:22 PM - 4:27 PM | Effect Of Exercise And Statins On Carotid Plaques: Implications For Invasive Treatment Of Asymptomatic Patients |
4:28 PM - 4:33 PM | Status Of The TACIT Trial: Will We Ever Know The Truth About How Asymptomatic Patients With Carotid Stenosis Should Be Treated?: Will The Stimulus Package Save The Day For TACIT? |
4:34 PM - 4:39 PM | Panel Discussion |
END OF SESSION 17 | |
SESSION 18 SCHEDULE | |
Thursday
SESSION 18:
UPDATE ON STENT GRAFTS IN THE SFA AND POPLITEAL ARTERIES (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
4:39 PM - 4:44 PM | 12-Year Experience With VIABAHN Stent-Grafts For Treatment Of Long SFA Occlusions: Technical Tips And 5 And 10-Year Patency Data |
4:45 PM - 4:50 PM | Single Center And Multicenter Results (VIBRANT Trial) Of VIABAHN Stent-Grafts vs. Uncovered Nitinol Stents For SFA Occlusive Disease |
4:51 PM - 4:56 PM | Edge Stenosis After SFA Stent-Grafting For Occlusive Disease: What Do We Know And What Can Be Done To Prevent Or Treat It: Will Heparin Bonding Improve Results? |
4:57 PM - 5:02 PM | Coverage Of Collaterals With SFA Stent-Grafts: Is It Or Is It Not A Problem? |
5:03 PM - 5:08 PM | Are Reentry Devices Worth The Effort In Complex SFA Occlusions? |
5:09 PM - 5:14 PM | 2-3-Year Results With Tissue Covered Stents For SFA Occlusive Disease: Technical Improvements In The System |
5:15 PM - 5:20 PM | Long-Term Follow-up Of VIABAHN Stent-Grafts To Treat Popliteal Aneurysms: Tips, Tricks, Precautions And When Not To Use |
5:21 PM - 5:26 PM | Panel Discussion |
END OF SESSION 18 | |
SESSION 19 SCHEDULE | |
Thursday
SESSION 19:
UPDATES AND NEW CONCEPTS IN VASCULAR DISEASE (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
5:26 PM - 5:31 PM | 2-3-Year Results With Drug Eluting Stents (DES): Does Catch-Up Stenosis And Mortality Occur And Why? |
5:32 PM - 5:37 PM | Midterm Efficacy And Long-Term Outlook With Coronary Drug Eluting Stents And Absorbable Drug Eluting Stents (The ABSORB Trial): Is There A Downside Beside Costs? |
Presenters(s):Martin B. Leon, MD | |
5:38 PM - 5:43 PM | Vulnerable Plaques: Implications For Vascular Surgeons And Interventionalists And What Can Be Done About Them? |
5:44 PM - 5:49 PM | Findings And Interpretations Of The SYNTAX Trial: Is It A Winner For Stenting Or CABG In Severe Coronary Artery Disease With Triple Vessel Or Left Main Disease? |
5:50 PM - 5:55 PM | Will Biodegradable Stents Replace Drug Eluting Stents? |
5:56 PM - 6:01 PM | Surgical And Endovascular Treatment Of Takayasu’s Arteritis: Which Treatment Should Be Used And When? |
6:02 PM - 6:07 PM | Radiation Exposure To The Interventionalist: Innovations And Precautions To Lessen It |
6:08 PM - 6:13 PM | Panel Discussion |
END OF SESSION 19 | |
SESSION 20 SCHEDULE | |
Thursday
SESSION 20:
PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
6:13 PM - 6:18 PM | Superficial Femoral Artery Access For Endovascular Procedures When The Common Femoral Cannot Be Used Due To Scarring, Disease Or Infection |
6:19 PM - 6:24 PM | Neurological Complications Of TEVAR: How To Prevent And Treat Them |
6:25 PM - 6:30 PM | Advantages Of And Indications For Use Of Bivalirudin Rather Than Heparin For Endovascular Procedures |
6:31 PM - 6:36 PM | Technical Tips On Managing Abdominal Compartment Syndrome And Open Abdomen Treatment After EVAR For Ruptured AAA |
6:37 PM - 6:42 PM | Techniques For Simplified Endovascular Management Of Iatragenic Subclavian Artery Injury |
6:43 PM - 6:48 PM | EMPIRE Trial Of The Gore Parodi Flow Reversal Embolic Protection Device In CAS: Its Particular Value In Symptomatic Patients And Octogenarians |
6:49 PM - 6:54 PM | Technique For Placement Of Large Palmaz Stent For Proximal Neck Problem During EVAR: What Balloon, Sheath And Precautions Are Needed? |
6:55 PM - 7:00 PM | Use Of Covered Palmaz Stent As A Neck Extender In EVAR |
Presenters(s):Ralf R. Kolvenbach, MD | |
7:01 PM - 7:06 PM | What The Vascular Surgeon Or Interventionalist Needs To Know About Discontinuing Plavix In A Patient With A Drug Eluting Coronary Stent Needing Another Procedure |
7:07 PM - 7:15 PM | Panel Discussion |
END OF SESSION 20 | |
Friday, November 20, 2009
Print Entire 2009 Program:
|
|
SESSION 21 SCHEDULE | |
Friday
SESSION 21:
MORE ABOUT NEW TECHNIQUES AND NEW TECHNOLOGY (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
6:40 AM - 6:45 AM | Technical Tips For Precise Placement Of A Large Palmaz Stent During EVAR |
6:46 AM - 6:51 AM | All Stents Are Not The Same: New And Improved Stents Can Improve Results: Are There Ways Other Than Drug Coatings To Improve Results? |
6:52 AM - 6:57 AM | ROX AV Fistula For Treatment Of COPD: Overview Of The European Experience |
6:58 AM - 7:03 AM | Muscle Sparing, Retroperitoneal Approach For Anterior Lumbar Spine Surgery With A PTFE Membrane (PRECLUDE Vessel Guard From Gore) To Protect The Aorta And IVC From Metal Fixation Hardware |
7:04 AM - 7:09 AM | Do Drug Eluting Stents In Crural Arteries Make A Difference In Below-the-Ankle Angioplasty And Stenting: The Last Frontier |
7:10 AM - 7:15 AM | Primary Intracranial Stenting For Acute Stroke: Early Results And When Not To Do It |
7:16 AM - 7:21 AM | Internal Sealing Of Ruptured AAAs With A Catheter Delivered Liquid-to-Solid Embolic Agent (ONYX): It Can Work |
7:22 AM - 7:28 AM | Panel Discussion |
END OF SESSION 21 | |
SESSION 22 SCHEDULE | |
Friday
SESSION 22:
MORE ABOUT THORACIC, THORACOABDOMINAL AND PARARENAL ANEURYSMS: FENESTRATED BRANCHED AND CHIMNEY GRAFTS (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
7:28 AM - 7:33 AM | First Description And Subsequent Experience With The “Chimney Or Snorkel” Procedure For Revascularizing Aortic Branches Threatened By Endograft Coverage |
7:34 AM - 7:39 AM | Present Status And New Developments In Use Of Chimney Grafts: They May Take The Place Of Many Fenestrated And Branched Grafts For Juxta- Para- And Suprarenal Aneurysms |
7:40 AM - 7:45 AM | Debate 14: Use Of Extended Chimney Grafts Facilitate Repair Of Suprarenal And Pararenal Aneurysms And Make The Need For Fenestrated And Branched Grafts Questionable |
Presenters(s):Armando C. Lobato, MD, PhD | |
7:46 AM - 7:51 AM | Debate 14: Fenestrated And Branched Grafts Are Not Threatened by Chimney Grafts |
7:52 AM - 7:57 AM | Updated 5-Year Experience With Fenestrated And Branched Endografts For Pararenal And Thoracoabdominal Aneurysms: Do They Work After Previous Open AAA Repair Or EVAR? |
7:58 AM - 8:03 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
8:03 AM - 8:08 AM | TEVAR Is The Best Treatment For Ruptured Thoracic Aneurysms: Technical Tips |
8:09 AM - 8:14 AM | Standardized Off-the-Shelf Multibranched Graft Components For Endovascular Thoracoabdominal Aneurysms Repair |
8:15 AM - 8:20 AM | Durability Issues With Branched Aortic Arch Endografts Make Fenestrated And Chimney Grafts In This Area Questionable As A Long-Term Solution |
8:21 AM - 8:26 AM | Open Surgery Is Still The Gold Standard For Repair Of Thoracoabdominal Aneurysms In Good Risk Patients |
Presenters(s):Richard P. Cambria, MD | |
8:27 AM - 8:32 AM | Scallop Designed Endograft To Improve Distal Sealing And Fixation With TEVAR |
8:33 AM - 8:38 AM | New Endovascular Stapler To Prevent Graft Migration After TEVAR |
Presenters(s):Ralf R. Kolvenbach, MD | |
8:39 AM - 8:44 AM | How Does 3-D CT Help In Prevention Of Spinal Cord Ischemia With TEVAR? |
8:45 AM - 8:52 AM | Panel Discussion |
END OF SESSION 22 | |
SESSION 23 SCHEDULE | |
Friday
SESSION 23:
NEW DEVELOPMENTS IN THE MANAGEMENT OF LOWER EXTREMITY ISCHEMIA (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
8:52 AM - 8:57 AM | Proportion Of Critical Ischemia Patients Who Require An Open Surgical Revascularization In A Center Favoring Endovascular Treatment |
8:58 AM - 9:03 AM | Adjuvant Benefit Of Angioplasty In Patients With Mild-to-Moderate Intermittent Claudication (MIMIC) Managed By Supervised Exercise, Smoking Cessation And Best Medical Treatment: Femoropopliteal Results |
9:04 AM - 9:09 AM | In The Endovascular Treatment Of Multilevel Occlusive Disease Causing Critical Limb Ischemia (CLI), Should The Distal Lesions Also Be Treated And Why? |
9:10 AM - 9:15 AM | Technical Tips And Tricks To Facilitate Difficult Lower Extremity Revascularization For CLI |
9:16 AM - 9:21 AM | The Evidence That Heparin-Bonded PTFE Grafts (PROPATEN) Are Better Than Uncoated PTFE And As Good As Vein Grafts: Where Do We Go From Here? |
9:22 AM - 9:27 AM | With PTA And Stents In The Aorta And Iliac Arteries, Is There Still A Place For Aortobifemoral Bypass? |
9:28 AM - 9:33 AM | New Developments In Open Surgery For Popliteal Aneurysms: Value Of Preop Thrombolysis, Posterior Approach And Postop Aneurysm Surveillance |
9:34 AM - 9:39 AM | Update On The Hanson Robotic System For Catheter Tip Manipulation And For Cannulating Aortic Branch Vessels |
9:40 AM - 9:45 AM | Tips And Tricks For The Successful Treatment Of Plantar And Diabetic Ulcers |
9:46 AM - 9:52 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
9:53 AM - 9:58 AM | Lysis (TPA) And Laser For Critical Limb Ischemia From Long Total Occlusions |
9:59 AM - 10:04 AM | Functional Status Of CLI Patients Predicts Outcome After Leg Bypass Surgery |
10:05 AM - 10:10 AM | How To Predict Patient Survival And Mortality In CLI Patients: Based On The BASIL Trial |
10:11 AM - 10:16 AM | Popliteal Entrapment Syndromes: What’s New With Classification, Pathogenesis And Treatment? |
10:17 AM - 10:22 AM | Optimal Antiplatelet And Anticoagulant Therapy With Lower Extremity Bypasses: Latest Best Treatment Based On Good Data |
10:23 AM - 10:28 AM | Status Of Bone Marrow And Stem Cell Transplants For CLI |
10:29 AM - 10:34 AM | Update On Angiogenic Gene Therapy For CLI: Where Is It Headed? |
10:35 AM - 10:43 AM | Panel Discussion |
END OF SESSION 23 | |
SESSION 24 SCHEDULE | |
Friday
SESSION 24:
ADVANCES IN MEDICAL TREATMENT AND TREATMENT OF MEDICAL PROBLEMS: MEDICAL RISKS IN VASCULAR SURGERY AND WHAT CAN BE DONE TO REDUCE THEM (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
10:43 AM - 10:48 AM | Factors Predictive Of Mortality In Vascular Surgery Patients From A NSQIP Database: Does Functional Status And Obesity Matter? |
10:49 AM - 10:58 AM | Update On Value Of Statin Drugs In Vascular Patients And The Over 50 Population: Should All Our Patients Be On Them; Should All Of Us Be On Them? (9-Minute Talk) |
10:59 AM - 11:04 AM | Primary Prevention Of Atherosclerosis: Should Everyone >50 Be On Statins; Should They Be In The Drinking Water? |
11:05 AM - 11:10 AM | How Should Statins Be Used Optimally: Dosage, Drug, Modulation Of Therapy According To Lipid Levels? |
11:11 AM - 11:16 AM | Value Of Continuous ECG Monitoring With An Implantable System (REVEAL XT) In Vascular Surgery Patients: What New Problems Can Be Detected And What Is The Prognostic Significance? |
11:17 AM - 11:22 AM | Medical Therapy And Advances In Critical Limb Ischemia: How Vascular Medicine And Cardiology Can Fundamentally Improve Outcomes |
11:23 AM - 11:28 AM | How Should Beta Blockers Be Used In Vascular Surgery Patients In Light Of The POISE Trial Showing They Can Increase Stroke And Death Rates? |
11:29 AM - 11:34 AM | Update On The RHEOS Trial Of Carotid Sinus Stimulation For Poorly Controlled Hypertension: Is It A New Horizons For Vascular Surgeons? |
11:35 AM - 11:50 AM | Panel Discussion |
11:50 AM - 12:48 PM | Lunch Served in the Exhibit Hall and in Other Designated Areas |
END OF SESSION 24 | |
SESSION 25 SCHEDULE | |
Friday
SESSION 25:
MORE ON AORTIC ANEURYSMS AND THEIR TREATMENT (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
12:48 PM - 12:53 PM | The New Cook PROFORM Thoracic Endograft To Provide Better Proximal Arch Conformability |
Presenters(s):Tilo Kölbel, MD, PhD | |
12:54 PM - 12:59 PM | A Multilayered Uncovered Stent For Treating Aneurysms With Preservation Of Branch Flow: Can It Really Work? |
Presenters(s):Edward B. Diethrich, MD | |
1:00 PM - 1:05 PM | Results Of French ACE Trial Comparing EVAR With Open Repair (OR) For Moderate Sized AAAs |
1:06 PM - 1:11 PM | 2-Year Results Of The U.S. VA Open vs. Endovascular AAA Repair (OVER) Trial |
Presenters(s):Frank A. Lederle, MD | |
1:12 PM - 1:17 PM | Are Long-Term Results Of EVAR Worse Than OR: Data From The Dutch DREAM Trial: What Other Findings Will Confirm Or Refute Them? |
1:18 PM - 1:23 PM | Update On The ENGAGE ENDURANT Global Registry: Why This Third Generation Device Is Better And Applicable To More Patients |
1:24 PM - 1:29 PM | Panel Discussion |
1:30 PM - 1:35 PM | Does EVAR And Its Follow-up Cause Renal Failure: What Should Be Done About It? |
1:36 PM - 1:41 PM | Proportion Of Ruptured AAAs Suitable For EVAR In View Of Chimney And Homemade Fenestrated Endografts |
Presenters(s):Timothy A. Resch, MD, PhD | |
1:42 PM - 1:47 PM | Debate 15: Should Type II Endoleaks Ever Be Treated: The Futility Of Intrasac Pressure Measurements |
1:48 PM - 1:53 PM | Debate 15: CardioMems Pressure Sensing Simplifies And Decreases The Cost Of Surveillance After EVAR And Helps To Determine When Type II Endoleaks Should Be Treated |
1:53 PM - 2:00 PM | Panel Discussion |
END OF SESSION 25 | |
SESSION 26 SCHEDULE | |
Friday
SESSION 26:
PROGRESS IN VASCULAR IMAGING AND MISCELLANEOUS TOPICS (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
2:00 PM - 2:05 PM | Advantages And Limitations Of CTA And MRA In Lower Limb Ischemia: 2009 State-of-the-Art For Preprocedural Imaging For Treatment Planning |
2:06 PM - 2:11 PM | How Does 3-D Rotational Angiography Help In Endovascular Procedures? |
2:12 PM - 2:17 PM | Update On New Developments In Intravascular Ultrasound And Its Applications For Endovascular And Vascular Procedures: What Can Be Accomplished With The VOLCANO System? |
2:18 PM - 2:23 PM | How Does Blood Pool MRA Contrast Agents Improve Vascular Imaging: How Do They Work? |
2:24 PM - 2:29 PM | What Is Possible With Improved 3-D And Dynamic 3-D (4-D) MRA And CTA Imaging? |
2:30 PM - 2:35 PM | 4-D Dynamic CT And Its Impact On Endograft Sizing |
2:36 PM - 2:41 PM | Pitfalls And Precautions With Aortic Imaging With CTA |
2:42 PM - 2:48 PM | Panel Discussion |
Moderator(s): TBD / TBD | |
2:48 PM - 2:53 PM | Why Brain MRI Studies Must Be Obtained Before Treatment Of Carotid Stenosis By CAS |
2:54 PM - 2:59 PM | The Importance Of Sub-Clinical Brain Damage After CAS vs. CEA: Correlations Between Serum Markers Of Neuronal Injury (NSE And S100 ß Proteins), Diffusion-Weighted MRI (DW-MRI) And Mini-Mental State Examination (MMSE) |
3:00 PM - 3:05 PM | Primary Vertebral Artery Aneurysms Are A Local Manifestation Of Connective Tissue Disease |
3:06 PM - 3:11 PM | Current Aspiration Catheter Techniques To Prevent Periprocedural And Post-Procedural Emboli During CAS |
3:12 PM - 3:17 PM | First Randomized Trial Showing Positive Results From Pharmacologically-Induced Angiogenesis (Gene Therapy) In Critical Limb Ischemia |
3:18 PM - 3:23 PM | Tips And Tricks To Make Pedal Bypass Successful And Valuable In The Endovascular Era: Does Deep Venous Arterialization Make A Difference? |
3:24 PM - 3:29 PM | Anatomical Suitability Of AAAs For EVAR In Ethnic Chinese: Which Graft Is Best For Most? |
3:30 PM - 3:36 PM | Panel Discussion |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Friday
SESSION 27:
PROGRESS IN VENOUS DISEASE AND ITS TREATMENT - PART I (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
3:36 PM - 3:42 PM | Open Surgical Large Vein Reconstruction: Does It Have A Role In The Era Of Endovenous Stenting? |
3:43 PM - 3:48 PM | The Monocusp Venous Valve: An Autologous Solution To Valvular Incompetence: Technique And Results |
3:49 PM - 3:54 PM | Use Of PTA And Stents After Thrombosis Of The IVC Following IVC Filter Placement: Does It Work And What Happens To The Filter? |
3:55 PM - 4:00 AM | Ultrasound Bedside Placement Of Removable IVC Filter (CELECT) In Trauma Patients |
4:01 PM - 4:06 PM | Diagnosis And Treatment Of The Nutcracker Syndrome Or Mesoaortic Compression Of The Left Renal Vein: Is It Best Treated With Stents, Coil Embolization Or Reimplantation? |
4:07 PM - 4:12 PM | What’s New About The Recent ACCP Guidelines For The Treatment Of DVT: Why Did They Change? |
4:13 PM - 4:19 PM | Panel Discussion |
Moderator(s): TBD / TBD | |
4:19 PM - 4:24 PM | Current Optimal Treatment For Ileofemoral DVT: How Best To Remove Clot? |
4:25 PM - 4:30 PM | New Developments In The Endovascular Treatment Of Venous And Arterial Trauma |
4:31 PM - 4:36 PM | With All These New Gadgets What Is The Best Method To Get Rid Of Clot With DVT? |
4:37 PM - 4:42 PM | Oral Contraceptive Use Can Cause Ileofemoral DVT In Women With Previously Undiagnosed May-Thurner Syndrome: How Should This Be Diagnosed And Treated? |
4:43 PM - 4:49 PM | Exciting New Developments In The Treatment Of Venous Disease From Around The World: Including Results From The JUPITER Trial Showing That Maintenance Statins Sharply Decrease The Incidence Of Venous Thromboembolism In Patients With Elevated CRP |
4:50 PM - 4:55 PM | Future Directions In Venous Disease Research And Treatment |
4:56 PM - 5:03 PM | Panel Discussion |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Friday
SESSION 28:
PROGRESS IN VENOUS DISEASE – PART II (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
5:03 PM - 5:08 PM | New Techniques For Treating Complicated DVT |
5:09 PM - 5:14 PM | Aggressive Interventional Treatment Of Chronic DVT: A New Method To Decrease The Symptoms Of The Post-Thrombotic Syndrome: Techniques And Early Results |
5:15 PM - 5:20 PM | Modern Treatment Of Central Large Vein Stenosis: To Stent Or Not To Stent |
5:21 PM - 5:26 PM | What Is The Best Current Treatment For Proximal Long Saphenous Vein Thrombophlebitis? |
5:27 PM - 5:32 PM | All Venous Ulcers Are The Same: So Why Should We Bother To Differentiate Between Primary And Secondary (Post-Thrombotic) Venous Disease? |
5:33 PM - 5:38 PM | Importance Of The Location Of Infrapopliteal DVT In The Incidence Of Pulmonary Emboli |
5:39 PM - 5:45 PM | Panel Discussion |
Moderator(s): TBD / TBD | |
5:45 PM - 5:50 PM | Use Of The ROTAREX Endovascular Mechanical Embolectomy Device For Treating Massive Pulmonary Emboli |
5:51 PM - 5:56 PM | What Is Necessary In A Venous Stent? |
5:57 PM - 6:02 PM | Acute DVT And Phlegmasia Cerulea Dolens In Children: Etiology And Treatment |
6:03 PM - 6:08 PM | Current Optimal Strategies And Techniques For Treating AV Malformations |
6:09 PM - 6:14 PM | Catheter Associated Upper Extremity DVT: Rates Of Progression, PE Potential, And Optimal Treatment |
6:15 PM - 6:25 PM | Panel Discussion |
END OF SESSION 28 | |
Saturday, November 21, 2009
Print Entire 2009 Program:
|
|
SESSION 29 SCHEDULE | |
Saturday
SESSION 29:
NEW DEVELOPMENTS IN THE TREATMENT OF AAAS: EVAR, OPEN REPAIR, LAPAROSCOPIC AND ROBOTIC REPAIR (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
6:40 AM - 6:45 AM | State-of-the-Art In Protecting Renal Function With Angiographic Procedures That Require Contrast |
6:46 AM - 6:51 AM | Endovascular Repair Of Mycotic Aneurysms: Should It Be First-Line Therapy? |
6:52 AM - 6:57 AM | Tips And Tricks For Doing Hybrid Procedures For Thoracoabdominal Aneurysms Successfully And With Less Morbidity |
6:58 AM - 7:03 AM | Off-the-Shelf Balloon Expandable Stent-Graft Can Replace Many Fenestrated Grafts With Juxtarenal AAAs And Others With “Impossible Necks” |
Presenters(s):Ralf R. Kolvenbach, MD | |
7:04 AM - 7:09 AM | Changes In Patient Fitness And EVAR Suitability During Surveillance Of Small AAAs: When Should Small AAAs Have Early Repair? |
7:10 AM - 7:15 AM | Results From The PIVOTAL Trial Comparing Observation And EVAR For Small AAAs |
7:16 AM - 7:21 AM | Results From The CAESAR Trial Comparing Observation With EVAR For Small AAAs |
7:22 AM - 7:31 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
7:31 AM - 7:41 AM | What Are The Limits Of Laparoscopic AAA Repair: When Is It Superior To EVAR: Is It Applicable To Juxta- And Pararenal AAAs? (10-Minute Talk) |
7:42 AM - 7:47 AM | Robotic Aortic Surgery: What Is Needed To Make It Work And What Is Its Future In The Endovascular Era? |
7:48 AM - 7:53 AM | Standard Open Repair Is Still The Preferred Treatment For AAA In Good And Moderate Risk Patients |
7:54 AM - 7:59 AM | Glasgow Aneurysm Score For Risk Estimation With Ruptured AAAs: What Is It And Is It Valid In The Endovascular Era: Is There A Better Method? |
8:00 AM - 8:05 AM | Debate 16: We Must Have A Trial With Ruptured AAAs Comparing Treatment With CT And EVAR When Possible To Open Repair (OR) |
8:06 AM - 8:11 AM | Debate 16: We Don’t Need A Randomized Trial Comparing OR And EVAR: If Done Right EVAR Is Clearly Better |
8:12 AM - 8:17 AM | Updated (2009) World Experience With EVAR For Ruptured AAAs: The Case That EVAR Is Better If The Anatomy Is Favorable |
8:18 AM - 8:26 AM | Panel Discussion |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Saturday
SESSION 30:
PROGRESS IN DISEASES OF THE AORTA AND ITS ABDOMINAL BRANCHES (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
8:26 AM - 8:31 AM | Present Status Of Renal Stenting: Results Of Randomized Comparisons Of Bare Metal Stents With Drug Eluting Stents (DES) And Best Medical Therapy: The Present Role Of Therapeutic Stenting And Prophylactic Stenting |
8:32 AM - 8:37 AM | Role Of Statins In Renal Artery Stenosis: What Is The Current Role For Renal Stenting And Embolic Protection? |
8:38 AM - 8:43 AM | Will Improved Renal Stenting Systems (Lower Profile, Rapid Exchange, DES, etc.) Make A Difference In Outcomes? |
8:44 AM - 8:49 AM | Renal Artery Stenting Under Embolic Protection With The FIBERNET Filter Device |
8:50 AM - 8:55 AM | Left Retroperitoneal Approach For Right Renal Artery Bypass |
8:56 AM - 9:01 AM | Treatment Of Renal Artery Aneurysms: Open Operation, Endovascular Treatments, Observation: When, How, Techniques And Tools |
9:02 AM - 9:07 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
9:08 AM - 9:13 AM | Current Treatment For Mid-Aortic Pararenal Coarctation: Is There A Role For Endovascular Treatment? |
9:14 AM - 9:19 AM | Is PTA And Stenting Safe For Classic Descending Aortic Coarctation: What Precautions Must Be Taken To Assure Safety: Is Open Surgery Ever Needed? |
Presenters(s):Christoph A. Nienaber, MD, PhD | |
9:20 AM - 9:25 AM | Stenting For Aortic Bifurcation Disease: Hugging Is Better Than Kissing |
9:26 AM - 9:31 AM | Technical Tips And Tricks For Visceral Artery Stenting |
9:32 AM - 9:37 AM | Treatment Of Visceral Artery Occlusive Disease: Are The Days Of Open Surgery Over? |
9:38 AM - 9:43 AM | Indications And Optimal Treatment For Visceral Artery Aneurysms: Lessons Learned From 200 Cases |
9:44 AM - 9:52 AM | Panel Discussion |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Saturday
SESSION 31:
THE FUTURE, ISSUES, CONCEPTS AND INTERACTION WITH GOVERNMENT (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
9:52 AM - 9:57 AM | A Look To The Future Of Vascular Disease Treatment |
Presenters(s):Edward B. Diethrich, MD | |
9:58 AM - 10:03 AM | New Products For Improved Endografting From Cook: Is There Anything For Type A Aortic Dissection? |
Presenters(s):Matt M. Thompson, MD | |
10:04 AM - 10:09 AM | Next Generation Devices For TEVAR: What’s In The Pipeline? |
10:10 AM - 10:15 AM | Why Are Drug Eluting Balloons Going To Work? |
10:16 AM - 10:21 AM | Burning Bridges With Endovascular Treatment: Does Aggressive Endovascular Therapy Lead To More Costly And Inferior Results For Some Patients: How Can We Be More Selective? |
10:22 AM - 10:27 AM | Increasing Mortality With Decreasing Number Of Patients Treated In A Given Hospital: Should There Be More Regionalization: Will It Decrease Costs? |
10:28 AM - 10:33 AM | Debate 17: Regulatory Procedures Are Necessary To Protect Patient Safety Even If They Inhibit Innovation Somewhat: The Status Quo In The U.S. Is Good |
10:34 AM - 10:39 AM | Debate 17: Regulatory Procedures Inhibit Innovation Greatly And The Status Quo With Them In The U.S. Is Bad |
10:40 AM - 10:45 AM | What Will Be The Toll Of U.S. Government Actions On The Device Industry And The Economy: Will We Outsource This Industry Too? |
10:46 AM - 10:52 AM | Panel Discussion |
END OF SESSION 31 | |
SESSION 32 SCHEDULE | |
Saturday
SESSION 32:
A TRIBUTE TO OUR MILITARY (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
10:52 AM - 10:54 AM | Introduction |
10:55 AM - 11:00 AM | Volunteer Vascular Surgery Program At Landstuhl Medical Center In Germany: A Civilian Perspective On Military Injuries |
11:01 AM - 11:06 AM | Use Of Prosthetic Grafts In Complex Vascular Trauma: An Altered New Limb Salvage Strategy For Patients With Limited Autologous Conduit |
11:07 AM - 11:12 AM | Surgical Response To Multiple Casualty Incidents From Single Explosive Events: Guidelines In The Modern Era |
11:12 AM - 11:15 AM | Questions And Answers |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Saturday
SESSION 33:
ISSUES RELATED TO BUSINESS, COSTS, SPECIALTY AND TRAINING (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
11:15 AM - 11:20 AM | New Coding And Reimbursement Issues And Tips For 2009 And 2010 |
11:21 AM - 11:26 AM | What Impact Will Health Care Reform Have On Vascular Surgery This Year And Next? |
11:27 AM - 11:32 AM | What Changes And Improvements Are Happening With The JVS In 2009 And Beyond? |
11:33 AM - 11:38 AM | Cost Savings From A Duplex Only Strategy For EVAR Surveillance After The 30-Day CT Scan |
11:39 AM - 11:44 AM | Improved System For Simulator Based Training In A Simulated Hybrid Operating Room |
11:45 AM - 11:50 AM | How To Get Medical Students To Go Into A 0 And 5 Vascular Surgery Training Program |
11:51 AM - 11:56 AM | Vascular Surgery Training Now And In The Future |
11:57 AM - 12:02 PM | Ideal Training Program In Vascular Surgery: Does It Need General Surgery? |
12:03 PM - 12:09 PM | Panel Discussion |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Saturday
SESSION 34:
LUNCHEON SESSION ON NEW AND IMPROVED TECHNQUES, ENDOGRAFTS AND DEVICES (5-MINUTE TALKS)
Moderators: / Matt M. Thompson, MD
|
|
x | |
12:10 PM - 12:15 PM | Update On The ANACONDA Graft For EVAR: Advantages And Limitations |
12:16 PM - 12:21 PM | Status Of The ENDURANT AAA Stent-Graft In The U.S. |
12:22 PM - 12:27 PM | The EVITA Graft For EVAR: Advantages And Limitations |
12:28 PM - 12:33 PM | U.S. Experience With The AORFIX Endograft: (Lombard Medical): Advantages, Limitations And Status Of The U.S. Trial |
12:34 PM - 12:39 PM | Advantages, Limitations And Experience With The RELAY PLUS Thoracic Endograft (Bolton Medical) |
12:40 PM - 12:45 PM | Update On The Status Of The U.S. Trial With The APTUS Endograft With Staple Fixation: Advantages, Technique And Limitations |
12:46 PM - 12:51 PM | Update On The Improved POWERLINK Endograft With IntuiTrak From Endologix With The IntuiTrak Express Delivery System For Easier Deployment: How Does It Work; Advantages; Limitations |
12:52 PM - 12:57 PM | The Ever Shrinking Profile Of Devices For EVAR: When Does It Matter? The New ZENITH Low Profile Device From Cook |
12:58 PM - 1:03 PM | Are New And Better Stents Possible: By What Approaches? |
1:04 PM - 1:10 PM | Panel Discussion |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Saturday
SESSION 35:
ETHICS, STANDARDS, REGISTRIES, RELATIONS WITH INDUSTRY, MALPRACTICE ISSUES (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
1:10 PM - 1:15 PM | What Is Happening To The Relationship Between Physicians, Industry And CME: Is Government And The ACCME Going To Block Industry Support For CME Activities? |
1:16 PM - 1:21 PM | Debate 18: Off-Label Use Of Devices By Physicians Is Acceptable: It Facilitates Patient Treatment |
1:22 PM - 1:27 PM | Debate 18: Off-Label Use Of Devices Is Not Acceptable In Most Instances: Reasons Why |
1:28 PM - 1:33 PM | Little Known Risks Of Hospital Or Institutional Malpractice Insurance Coverage |
1:34 PM - 1:39 PM | Randomized Controlled Trials With Patient Groups Or Arms Getting No Treatment Or Observation Are Inherently Flawed: Why And What Can Be Done About It? |
1:40 PM - 1:45 PM | Should We Have Reporting Standards For Endovascular Interventions: How Will We Get Them? |
1:46 PM - 1:51 PM | Evolution Of The Northern New England Vascular Registry: New Information Regarding AAA Repair And Carotid Endarterectomy |
1:52 PM - 2:00 PM | Panel Discussion |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Saturday
SESSION 36:
VASCULAR DISEASE NATURAL HISTORY, MEDICAL TREATMENTS AND PREVENTION, AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
2:00 PM - 2:05 PM | Long-Term Cardiac Outcomes Of High Risk AAA Patients After EVAR And OR |
2:06 PM - 2:11 PM | Does The Presence Of An AAA Protect Against Stroke: Why Is This So? |
2:12 PM - 2:17 PM | Hybrid Technique To Treat Infected Vascular Grafts With An Endograft, Drainage And A VAC Dressing: When Can They Work? |
2:18 PM - 2:23 PM | Pharmacologic Approaches To Spinal Cord Protection |
2:24 PM - 2:29 PM | What Technical Maneuvers Can Help The CAS Operator Deal With Inability To Retrieve Filters, No Flow Through The Filter, Heavily Calcified Lesions And Intolerance To Flow Arrest |
2:30 PM - 2:35 PM | Innovative Endovascular Treatments Of Complex Failures Of Previous EVAR Procedures: These Bailouts Include Use Of Fenestrated Cuffs |
2:36 PM - 2:41 PM | Tips And Tricks To Allow Endovascular Treatment Of Complex Limb Disconnects After EVAR |
2:42 PM - 2:47 PM | Iron Stores, Inflammation And Biomarkers: How Do They Influence Atherosclerosis: Do Statins Help? |
2:48 PM - 2:53 PM | Technical Tips On The Use Of ONYX In The Treatment Of Type II Endoleaks |
2:54 PM - 3:08 PM | Panel Discussion |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Saturday
SESSION 37:
UPDATES AND NEW TECHNIQUES (4-MINUTE FAST-PACED TALKS)
Moderators: / TBD
|
|
x | |
3:08 PM - 3:12 PM | How To Predict AAA Rupture By Looking At Wall Stress, Wall Strength And Extent Of Intraluminal Thrombus |
3:13 PM - 3:17 PM | With TEVAR What Is The Best Way To Decrease Flow And Minimize Migration During Deployment: The Myth Of Lowering BP For Deployment Of Thoracic Endografts |
3:18 PM - 3:22 PM | Exceptional Way To Treat Infected Aneurysmal Sac Due To Aorto-Esophageal Fistula |
3:23 PM - 3:27 PM | What Is The Role Of A Flexible Kink-Resistant Stent-Graft:7-Year Clinial Experience With The AORFIX Aortic Endograft For AAAs |
3:28 PM - 3:32 PM | Debate 19: No Patient Should Undergo CAS Without Embolic Protection |
3:33 PM - 3:37 PM | Debate 19: There Are Patients Who Should Undergo CAS Without Embolic Protection |
3:38 PM - 3:42 PM | The FDA's Current Position On Embolic Protection Devices During CAS |
3:43 PM - 3:47 PM | New Simplified Sutureless Device For End-to-Side Aortic Anastomoses |
3:48 PM - 3:52 PM | The Un-Balloon Non-Occlusive Modeling Catheter: A Better Answer To Aortic Stent-Graft Forced Expansion For Modeling |
3:53 PM - 3:57 PM | How Best To Revascularize Occluded Mesenteric Artery: When Is PTA And Stenting Safe, And When Is Open Surgery Best Based On A Large Clinical Experience? |
3:58 PM - 4:04 PM | Panel Discussion |
Moderator(s): TBD / TBD | |
4:04 PM - 4:08 PM | How To Create A Hybrid Operating Room |
4:09 PM - 4:13 PM | Optimal Sequence And Staging For Patients Who Need Coronary And Carotid Procedures (CAS or CEA) |
4:14 PM - 4:18 PM | When Is Laparoscopic Treatment Of Type II Endoleaks Required: What Are The Technical Requirements: How Much Laparoscopic Experience Is Needed? |
4:19 PM - 4:23 PM | Celiac Artery Coverage During TEVAR Is Safe Acutely And Midterm: When Should It Be Avoided? |
4:24 PM - 4:28 PM | Errors In Determining AAA Diameter With Ultrasound Compared To 3-D CTA: Its Importance In Evaluating The ADAM And UK Small Aneurysm Trials |
Presenters(s):Timothy A. Resch, MD, PhD | |
4:29 PM - 4:33 PM | Do TEVAR Outcomes Differ For Acute And Chronic Type B Aortic Dissections And Why? |
4:34 PM - 4:38 PM | Indications For Statin In Patients Undergoing EVAR: When Should They Be Started And At What Dose? |
4:39 PM - 4:43 PM | Debate 20: Failed Endografts Requiring Open Surgery Usually Mandate Graft Removal: Tips For Doing This Safely |
4:44 PM - 4:48 PM | Debate 20: Open Surgical Salvage Of Failed Endograft Without Graft Removal Is Usually Possible: Technical Tips For Accomplishing This |
4:49 PM - 4:55 PM | Panel Discussion |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Saturday
SESSION 38:
MORE UPDATES AND NEW TECHNIQUES (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
4:55 PM - 5:00 PM | Adverse Event Rates For CAS And CEA From The SVS Registry |
5:01 PM - 5:06 PM | Tips And Tricks For Anterior Exposure Of The Spine By Vascular Surgeons |
5:07 PM - 5:12 PM | Diagnosis And Treatment Of Arterial Aneurysms In Patients With Behçet Disease |
5:13 PM - 5:18 PM | Duplex Velocities Determine Need For CAS After CEA With Neurological Symptoms; Without Symptoms |
5:19 PM - 5:24 PM | Men And Women With AAAs Behave Differently And Different Guidelines Are Needed |
5:25 PM - 5:30 PM | 3-D CT Localization Of Artery Of Adamkiewitz: Is It Accurate? |
5:31 PM - 5:36 PM | Role Of Endovascular Techniques In Treatment Of Carotid Body Tumors |
5:37 PM - 5:43 PM | Panel Discussion |
Moderator(s): TBD / TBD | |
5:43 PM - 5:48 PM | The Bridge Graft With Vein And PTFE: A New Option For CLI With 15 Years Follow-up Showing Endothelialization Of The PTFE |
5:49 PM - 5:54 PM | Tips And Tricks For Intracranial Neuro Rescue During And After CAS |
5:55 PM - 6:00 PM | Simple Method To Measure Trans-Stenotic Pressure Gradient Accurately |
6:01 PM - 6:06 PM | How To Cool The Kidneys To Protect Them During Open Pararenal Aortic Surgery |
6:07 PM - 6:12 PM | Use Of Amplatz Septal Occluder For Gunshot Wound Of The Aorta |
6:13 PM - 6:18 PM | Advantages Of The TAArget Endograft For TEVAR: 3-Year Experience At A Single Center |
6:19 PM - 6:25 PM | Panel Discussion |
END OF SESSION 38 | |
Sunday, November 22, 2009
Print Entire 2009 Program:
|
|
SESSION 39 SCHEDULE | |
Sunday
SESSION 39:
NEW DEVELOPMENTS, TECHNIQUES AND CONCEPTS (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
6:45 AM - 6:50 AM | What Proportion Of AAAs Can Be Treated With Current Endografts? |
6:51 AM - 6:56 AM | Use Of Duplex Imaging To Detect Common Femoral Artery Injuries During EVAR |
6:57 AM - 7:02 AM | Tips And Tricks In The Endovascular Treatment Of Large A-V Fistulas |
7:03 AM - 7:08 AM | Virtual Angioscopy Of The Thoracic And Abdominal Aorta: Is It A Useful Tool Or A Fancy Toy? |
7:09 AM - 7:14 AM | Tips And Tricks To Make TIPS Procedures Effective Using Stent-Grafts |
7:15 AM - 7:20 AM | How To Use Clopidigrel (Plavix) To Make CEA Safer |
7:21 AM - 7:26 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
7:26 AM - 7:31 AM | Myths And Little Known Facts About Collateral Development With Major Arterial Occlusion |
7:32 AM - 7:37 AM | Minimally Invasive Approach To Treat The Median Arcuate Ligament Syndrome: Technique And Results |
7:38 AM - 7:43 AM | Chronic Lymphedema: How Best To Treat It: Are There Still Surgical Options? |
7:44 AM - 7:49 AM | Technical Tips For Crossing Long Tibial Occlusions |
7:50 AM - 7:55 AM | Are Reentry Devices Necessary When Crossing Most Long Totally Occluded Segments? |
7:56 AM - 8:01 AM | New Developments And Updated Results With Duplex Guided PTA And Stenting |
8:02 AM - 8:08 AM | Panel Discussion |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Sunday
SESSION 40:
MORE ABOUT THORACIC AND ABDOMINAL ANEURYSMS (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
8:08 AM - 8:13 AM | 10-Year Results After EVAR vs. 10-Year Results After Open Repair |
8:14 AM - 8:19 AM | Updated Data On Safety Of Bilateral Hypogastric Interruption With EVAR And OR: Cooperative Study In 135 Patients |
8:20 AM - 8:25 AM | Endovascular Treatment Of Iliac Aneurysms Involving The Hypogastric Artery: Concurrent Comparison Of Branched Endografts vs. Hypogastric Occlusion |
8:26 AM - 8:31 AM | Significance Of Mesenteric Arteries During EVAR |
8:32 AM - 8:37 AM | Debate 21: With EVAR Outcomes Are Not Influenced By AAA Size |
8:38 AM - 8:43 AM | Debate 21: With EVAR Outcomes Are Influenced By Size: Big Is Bad |
8:44 AM - 8:49 AM | Can Positron Emission Tomography (PET) Imaging And Biochemical Analysis Help To Predict AAA Rupture? |
8:50 AM - 8:56 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
8:56 AM - 9:01 AM | Technique For Fascial Suture To Close Puncture Sites For Percutaneously Placed Large Sheaths: It Works But It Has To Be Done Right (Video Presentation) |
9:02 AM - 9:07 AM | Tips And Tricks For Improving Results Or Managing Tortuous Or Adverse Neck Anatomy With The Gore Excluder Graft |
9:08 AM - 9:13 AM | New Developments In The Management Of Graft Enteric (Aortoduodenal) Fistulas: Successful In Situ Repair With Silver Impregnated, Rifampin Soaked Grafts |
9:14 AM - 9:19 AM | Advantages And Limitations Of The New Medtronic Valiant Captivia Stent-Graft For TEVAR |
Presenters(s):Matt M. Thompson, MD | |
9:20 AM - 9:25 AM | Adjuvant Maneuvers To Affect Graft Tilt During EVAR With Angulated Necks: Should We Try To Fit The Aorta To The Graft Or Should We Try To Fit The Graft To The Aorta – And How? |
9:26 AM - 9:31 AM | Off-The-Shelf Device For EVAR Treatment Of Juxtarenal Aneurysms |
9:32 AM - 9:38 AM | Panel Discussion |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Sunday
SESSION 41:
NEW DEVELOPMENTS IN DISEASES OF THE CAROTIDS, VERTEBRALS AND SUPRA-AORTIC TRUNKS (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
9:38 AM - 9:43 AM | Debate 22: Covered Stents Are Good For The Treatment Of Carotid Artery Aneurysms |
9:44 AM - 9:49 AM | Debate 22: Endovascular Repair Of Extracranial Carotid Aneurysms Is Still A Hazardous Procedure |
9:50 AM - 9:55 AM | Mortality And Cost Implications For Delaying Treatment After A TIA Or Small Stroke Are Serious: How To Facilitate Early Treatment: The EXPRESS Trial |
9:56 AM - 10:01 AM | Determinants And Late Clinical Significance Of Microemboli With CAS And CEA: When Do They Matter? |
10:02 AM - 10:07 AM | Dos And Don’ts Of Endovascular Management Of Carotid Trauma |
10:07 AM - 10:20 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
10:20 AM - 10:25 AM | Routine Shunting vs. Selective Shunting In CEA Based On Stump Pressure: Which Is Best Based On A Randomized Controlled Trial? |
10:26 AM - 10:31 AM | New Portable Multisensor Transducer For Carotid Screening By Non-Specialized Office Personnel |
10:32 AM - 10:37 AM | Update On Population Based Studies Comparing Adverse Event Rates With CAS And CEA In The U.S.: Are CAS Results Improving? |
10:38 AM - 10:43 AM | Diagnosis And Treatment Of Vulnerable Carotid Plaques Causing TIAs Or Strokes: When Should They Be Treated By CEA Or By CAS? |
10:44 AM - 10:49 AM | Tips And Tricks For The Endovascular Treatment Of Subclavian And Innominate Stenosis |
10:50 AM - 10:55 AM | Update On Treatment Of Acute Stroke By IV Thrombolysis And CEA: Why CEA Not CAS: Advantages And Limitations |
10:56 AM - 11:03 AM | Panel Discussion |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Sunday
SESSION 42:
NEW DEVELOPMENTS IN CAS (4-MINUTE FAST PACED TALKS)
Moderators: / TBD
|
|
x | |
11:03 AM - 11:07 AM | What The Trial And Registry Results To Date Tell Us About The Present Status Of CAS: What Are The Prospects For A Change In This Status In The Future? |
11:08 AM - 11:12 AM | How To Lower Risk Of CAS In Octogenerians And Other High Risk Patients |
11:13 AM - 11:17 AM | Combined Carotid And Coronary Procedures: Nationwide Statistics Show That CAS Has Lower Adverse Events Rates Than CEA |
11:18 AM - 11:22 AM | CAS Experience With Endovascular Flow Interruption Using The MOMA Device: Advantages And Limitations |
11:23 AM - 11:27 AM | Use Of IVUS As An Important Quality Control Technique For CAS: Are There Risks To Its Use? |
11:28 AM - 11:32 AM | Debate 23: Screening To Detect Asymptomatic Carotid Stenosis Is Worthwhile So It Can Be Treated By CAS Or CEA |
11:33 AM - 11:37 AM | Debate 23: Screening To Detect Asymptomatic Carotid Stenosis Is A Bad Thing To Do Except As A Way To Get Patients On Statins: CAS Or CEA In Asymptomatic Patients Consumes Resources But Does Little To Prevent Stroke |
11:38 AM - 11:42 AM | Carotid Interventions For Stroke In Evolution: Indications, Techniques And Results: A 5-Year Experience |
11:43 AM - 11:47 AM | CAS Setbacks: The Plan Was Flawed From The Beginning: Will CAS Recover? |
11:48 AM - 11:52 AM | Carotid Stenting For Radiation Arteritis Has A High Complication And Restenosis Rate |
11:53 AM - 11:59 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
11:59 AM - 12:03 PM | Clinical Course Of Asymptomatic Carotid Stenosis With End-Diastolic Velocity 100-125 cm/sec: Stent Or Observe? |
12:04 PM - 12:08 PM | Technique Of Using An Interruption Of Flow Embolic Protection Device (MOMA) To Make CAS Safer |
12:09 PM - 12:13 PM | How To Identify Stroke Threatening Plaques In Asymptomatic Patients By Contrast Duplex Or Biochemical Markers (Alpha NT pro BNP) |
12:14 PM - 12:18 PM | The Value Of Pre-Procedure CTA To Improve The Outcomes Of CAS |
12:19 PM - 12:23 PM | Restenosis After CAS Is Equal To That After CEA Based On Long-Term Results In 1,000 Patients |
12:24 PM - 12:28 PM | Transcervical CAS With Flow Reversal Eliminates Emboli During CAS: Why Does It Work And What Are The Adverse Event Rates With This Approach? |
12:29 PM - 12:33 PM | Outcomes After CEA: Is There A High Risk Population And Does This Have A Bearing On Some Of The CAS Trials Such As SAPPHIRE? |
Presenters(s):Richard P. Cambria, MD | |
12:34 PM - 12:45 PM | Panel Discussion Refreshments Available |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Sunday
SESSION 43:
NEW CONCEPTS, ADVANCES, LATE BREAKING INFORMATION (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
12:45 PM - 12:50 PM | Debate 24: Transcranial Doppler During CAS: When And Why Is Flow Reversal With The Gore-Parodi Device Better? |
12:51 PM - 12:56 PM | Debate 24: Why Flow Cessation During CAS (With The MOMA Device) Is Better: The ARMOUR Trial |
12:57 PM - 1:02 PM | Update On Results From The ACT Trial Comparing CEA And CAS With Protection In Asymptomatic Patients With Carotid Stenosis |
1:03 PM - 1:08 PM | Tips And Tricks To Allow Large Sheath Access For TEVAR And EVAR: Alternatives To External Conduits When Iliac Arteries Are Too Small Or Diseased To Allow Femoral Access |
1:09 PM - 1:14 PM | Noninvasive Treatment For CLI With A Sequential Compression Device: Does It Work? |
1:15 PM - 1:20 PM | What Are The Results And Complications With The TAG Endograft When It Is Used More Widely And Not Only In Centers Of Excellence (The Post Marketing Approval Trial)? |
1:21 PM - 1:26 PM | Treatment Of Iliac Aneurysms By Off-Label Modified Use Of Reversed ZENITH Limb Extensions: Technical Tips |
1:27 PM - 1:32 PM | What Is The Value Of C-Arm CT Scanning In EVAR Procedures And Patients? |
Presenters(s):Matt M. Thompson, MD | |
1:33 PM - 1:38 PM | The NELLIX Sac Anchoring Endoprosthesis For AAA Exclusion: A New Concept For EVAR |
1:39 PM - 1:44 PM | Advantages To 3-D Imaging (With M2S, TeraRecon, Or 3-Mensio) In Planning For Standard Infrarenal EVAR Procedures |
1:45 PM - 1:53 PM | Panel Discussion |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Sunday
SESSION 44:
NEW CONCEPTS, ADVANCES AND LATE BREAKING INFORMATION (5-MINUTE TALKS)
Moderators: / TBD
|
|
x | |
1:53 PM - 1:58 PM | New Developments In The Treatment Of Fibromuscular Dysplasia |
1:59 PM - 2:04 PM | When To Stent Renal Artery Stenosis With EVAR And What To Do For Restenosis |
2:05 PM - 2:10 PM | HYPERMED Camera For Measuring Cutaneous O2 Saturation Before And After Intervention: How Does It Help? |
2:11 PM - 2:16 PM | Cutting Balloon Facilitates CAS With Very Calcified Plaques: What Are The Dangers? |
2:17 PM - 2:22 PM | CAS Is Appropriate In Asymptomatic Patients But Not In Symptomatic Patients: CMS Has It Wrong |
2:23 PM - 2:28 PM | Endografts Can Serve As A Bridge To Definitive Repair: When And How Can This Be Helpful? |
2:29 PM - 2:34 PM | Lower Extremity Arterial Flow Is Decreased In Patients With Venous Disease: Why Does It Matter? |
2:35 PM - 2:40 PM | EVAR Without Contrast Is Safe: How To Do It |
2:41 PM - 2:46 PM | Covered Stents Will Improve Treatment For Renal Artery Stenosis |
2:47 PM - 2:52 PM | Cerebral Hyperfusion Syndrome Is Not What You Think: We Have Been Misled |
2:53 PM - 3:00 PM | Panel Discussion |
3:00 PM - 3:05 PM | Raffle Prize Drawing for fully paid, clinician attendees. You must be present to win. |
3:05 PM - 3:05 PM | Symposium Ends |
END OF SESSION 44 | |